-
Something wrong with this record ?
Karcinom prsu s amplifikací HER2 : mechanismy rezistence vůči trastuzumabu a nové možnosti cílené léčby
Devika Gajria a Sarat Chandarlapaty
- Published
- Praha : Content Ed Net, 2011
- Pagination
- 263-275 s. : il., tab. ; 28 cm
Language Czech Country Czech Republic
Persistent link
https://www.medvik.cz/link/MED00178103
- MeSH
- Gene Amplification MeSH
- Drug Resistance, Neoplasm MeSH
- Genes, erbB-2 MeSH
- Drug Delivery Systems MeSH
- Neoplasm Metastasis drug therapy MeSH
- Antibodies, Monoclonal MeSH
- Breast Neoplasms drug therapy MeSH
- Receptor, ErbB-2 MeSH
- Conspectus
- Farmacie. Farmakologie
- NML Fields
- onkologie
- gynekologie a porodnictví
- farmacie a farmakologie
- NML Publication type
- studie
Original
HER2-amplified breast cancer- mechanisms of trastuzumab resistance and novel targeted therapies. Knihovny.cz
Reprint: Expert review of anticancer therapy 11 (2), 263-275 (2011)
Bibliography, etc.Obsahuje literaturu
Owner | Details | Services | |||||
---|---|---|---|---|---|---|---|
NLK | NLK Shelf no. DT 10046 [1] | ||||||
Loading data ...
|
- 000
- 00000nam 2200000 a 4500
- 001
- MED00178103
- 003
- CZ-PrNML
- 005
- 20141219173837.0
- 008
- 120521s2011 xr e cze||
- 009
- BK
- 020 __
- $q (Brož.)
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 1_
- $a cze $h eng
- 044 __
- $a xr $c CZ
- 072 _7
- $x Farmacie. Farmakologie $a 615 $2 Konspekt $7 sk136315
- 080 __
- $a 616-006 $2 h
- 080 __
- $a 618.1 $2 h
- 080 __
- $a 615.2 $2 h
- 080 __
- $a 615.03/.099 $2 h
- 100 1_
- $a Gajria, Devika $4 aut $7 xx0152247
- 245 10
- $a Karcinom prsu s amplifikací HER2 : $b mechanismy rezistence vůči trastuzumabu a nové možnosti cílené léčby / $c Devika Gajria a Sarat Chandarlapaty
- 260 __
- $a Praha : $b Content Ed Net, $c 2011
- 300 __
- $a 263-275 s. : $b il., tab. ; $c 28 cm
- 500 __
- $a Reprint: Expert review of anticancer therapy 11 (2), 263-275 (2011)
- 504 __
- $a Obsahuje literaturu
- 650 07
- $a onkologie $2 mednas $7 nlk20040148136
- 650 07
- $a gynekologie a porodnictví $2 mednas $7 nlk20040147647
- 650 07
- $a farmacie a farmakologie $2 mednas $7 nlk20040147252
- 650 07
- $a nádory prsu $x farmakoterapie $2 czmesh $7 D001943
- 650 07
- $a metastázy nádorů $x farmakoterapie $2 czmesh $7 D009362
- 650 07
- $a geny erbB-2 $2 czmesh $7 D018734
- 650 07
- $a amplifikace genu $2 czmesh $7 D005784
- 650 07
- $a monoklonální protilátky $2 czmesh $7 D000911
- 650 07
- $a receptor erbB-2 $2 czmesh $7 D018719
- 650 07
- $a chemorezistence $2 czmesh $7 D019008
- 650 07
- $a lékové transportní systémy $2 czmesh $7 D016503
- 655 _4
- $a studie $7 nlk-pt140
- 700 1_
- $a Chandarlapaty, Sarat $4 aut $7 xx0152251
- 765 0_
- $t HER2-amplified breast cancer- mechanisms of trastuzumab resistance and novel targeted therapies $9 Česky
- 910 __
- $a ABA008 $b DT 10046 $y 3
- 990 __
- $a 20120329142711 $b ABA008
- 991 __
- $a 20120621095825 $b ABA008
- 999 __
- $a ok $b medvik21 $g 903986 $s 182150
- BAS __
- $a 01 $a 11 $a 30
- LZP __
- $b 22/15.2.2012